Recommendations for HER2+ Breast Cancer Treatment

Understanding Recommendations for HER2+ Breast Cancer Treatment in Canada HER2-positive (HER2+) breast cancer is a more aggressive form of breast cancer, affecting about 14% of patients. Thankfully, breakthroughs in targeted therapies over the years have improved outcomes for those living with this condition. But even with these advances, gaps remain in how treatments are provided […]

Join Us at the Canadian Reception at SABCS

Breast Cancer Canada is excited to host an exclusive evening of networking and national research announcements at the San Antonio Breast Cancer Symposium. We warmly invite Canadian oncologists, researchers, and industry leaders to connect with peers, share insights, and explore the latest advancements in breast cancer progress. Canadian Reception Wednesday, December 11th, 2024 at 5:30 […]